Waters Co. (NYSE:WAT) has received an average recommendation of “Hold” from the nineteen research firms that are currently covering the stock, MarketBeat Ratings reports. Twelve equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $200.93.
WAT has been the subject of several research reports. BTIG Research initiated coverage on shares of Waters in a research note on Friday, January 5th. They set a “buy” rating and a $230.00 price target for the company. Zacks Investment Research raised shares of Waters from a “hold” rating to a “buy” rating and set a $211.00 price target for the company in a research note on Monday, October 23rd. Janney Montgomery Scott raised their price target on shares of Waters from $200.00 to $230.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Morgan Stanley raised shares of Waters from an “underweight” rating to an “equal weight” rating and set a $192.00 price target for the company in a research note on Monday, December 4th. Finally, Barclays raised their price target on shares of Waters from $188.00 to $193.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 25th.
In other Waters news, Director Thomas P. Salice sold 3,500 shares of the firm’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $200.03, for a total transaction of $700,105.00. Following the completion of the sale, the director now owns 20,349 shares of the company’s stock, valued at approximately $4,070,410.47. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark T. Beaudouin sold 42,143 shares of the firm’s stock in a transaction on Thursday, January 25th. The shares were sold at an average price of $217.21, for a total value of $9,153,881.03. Following the sale, the senior vice president now directly owns 20,749 shares of the company’s stock, valued at approximately $4,506,890.29. The disclosure for this sale can be found here. In the last three months, insiders sold 124,789 shares of company stock valued at $26,083,647. 5.07% of the stock is currently owned by insiders.
Waters (WAT) opened at $203.26 on Tuesday. The firm has a market cap of $16,170.00, a P/E ratio of 1,129.22, a PEG ratio of 2.54 and a beta of 0.88. Waters has a 52 week low of $144.66 and a 52 week high of $220.20. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.97 and a current ratio of 2.10.
Waters (NYSE:WAT) last issued its quarterly earnings results on Tuesday, January 23rd. The medical instruments supplier reported $2.51 earnings per share for the quarter, topping the consensus estimate of $2.44 by $0.07. The company had revenue of $687.28 million during the quarter, compared to analysts’ expectations of $671.98 million. Waters had a net margin of 0.88% and a return on equity of 24.70%. The business’s quarterly revenue was up 9.3% on a year-over-year basis. During the same period last year, the business earned $2.21 EPS. equities research analysts predict that Waters will post 8.16 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Waters Co. (WAT) Given Consensus Recommendation of “Hold” by Brokerages” was reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/02/06/waters-co-wat-given-consensus-recommendation-of-hold-by-brokerages.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.